Deise Catamo Vaz/LinkedIn
Apr 2, 2026, 14:18
Deise Catamo Vaz: Closing A Large Information Gap in PSCI Through WSO Future Stroke Leaders Project
Deise Catamo Vaz, Neurologist at UEM Cardiology Research Center, shared on LinkedIn:
”The Post-stroke cognitive impairment (PSCI) is a significant, yet often overlooked, cause of persistent disability, affecting over one-third of stroke survivors.
However, we have limited knowledge about global practices and barriers in screening for cognitive impairment among stroke survivors.
We present our global project, divided into two phases:
- Survey and systematic review, led by members of the World Stroke Organization (WSO) Future Stroke Leaders Programme (FSLP), seeks to address this gap.
- Our main objective with this project is to understand the current situation and knowledge of healthcare professionals who care for patients after stroke globaly, with a strong emphasis in LMICs.
At the end of this project, we will have more information to improve the diagnosis of PSCI and vascular dementia, especially in LMICs, closing a large information gap in these area.
World Stroke Organization Future Stroke Leaders Cohort-3.”

Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care